NOBO Medicine Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $20M

  • Investors
  • 16

NOBO Medicine General Information

Description

Operator of a research and development company intended to provide risk analysis services for various diseases through molecular diagnosis. The company develops biomarkers through bioinformatics technology and performs precision medicine, such as diagnosis and targeted drug development, enabling healthcare workers to perform molecular diagnoses through technology and diverse experiences.

Contact Information

Website
www.nobomedicine.com
Formerly Known As
Genome Opinion
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 613, Seongsu-dong The Live Sejong Tower
  • 126 Achasan-ro
  • Seoul, 04783
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Room 613, Seongsu-dong The Live Sejong Tower
  • 126 Achasan-ro
  • Seoul, 04783
  • South Korea
+82

NOBO Medicine Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NOBO Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 28-Jul-2025 $20M Completed Clinical Trials - Phase 2
5. Accelerator/Incubator Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B) 30-Nov-2022 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series A) 30-Nov-2020 Completed Startup
2. Seed Round 24-Apr-2018 Completed Startup
1. Accelerator/Incubator 01-Feb-2018 Completed Startup
To view NOBO Medicine’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

NOBO Medicine Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

NOBO Medicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023013998-A1 Biomarker for prognosis of lung cancer treatment and use thereof Inactive 02-Aug-2021
WO-2022220624-A1 Method for predicting risk of atherosclerotic cardio-cerebrovascular diseases by using blood cell mutant information Inactive 15-Apr-2021
WO-2022119327-A1 Method for measuring risk of cardio-cerebrovascular disease using congenital metabolic disease risk score Inactive 02-Dec-2020
WO-2022039565-A1 Biomarker for diagnosing age-related macular degeneration, and use thereof Inactive 20-Aug-2020
JP-2023539474-A Biomarkers for diagnosis of age-related macular degeneration and their uses Pending 20-Aug-2020 C12Q1/6883
To view NOBO Medicine’s complete patent history, request access »

NOBO Medicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NOBO Medicine Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Curocell Corporation Minority
Dongkuk Holdings Company Corporation Minority
G.N. Tech Venture Capital Venture Capital Minority
Industrial Bank of Korea PE/Buyout Minority
Korea Investment & Securities Asset Manager Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

NOBO Medicine FAQs

  • When was NOBO Medicine founded?

    NOBO Medicine was founded in 2017.

  • Where is NOBO Medicine headquartered?

    NOBO Medicine is headquartered in Seoul, South Korea.

  • What is the size of NOBO Medicine?

    NOBO Medicine has 12 total employees.

  • What industry is NOBO Medicine in?

    NOBO Medicine’s primary industry is Drug Discovery.

  • Is NOBO Medicine a private or public company?

    NOBO Medicine is a Private company.

  • What is NOBO Medicine’s current revenue?

    The current revenue for NOBO Medicine is .

  • How much funding has NOBO Medicine raised over time?

    NOBO Medicine has raised $27.3M.

  • Who are NOBO Medicine’s investors?

    Curocell, Dongkuk Holdings Company, G.N. Tech Venture Capital, Industrial Bank of Korea, and Korea Investment & Securities are 5 of 16 investors who have invested in NOBO Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process